Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Sorafenib and Cyclophosphamide/Topotecan in Patients With Relapsed and Refractory NeuroblastomaDisease Attributes, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neuroectodermal Tumors, Primitive, Neuroectodermal Tumors, Primitive, Peripheral, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, epithelial neoplasm, neoplasm, neuroblastoma, neuroepithelial neoplasm, primitive neuroectodermal tumorActive, not recruitingPhase 12026-03-23NCT02298348

13 results · Page 1 of 1

12 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
C.S Mott Children's HospitalAnn ArborUnited States7
Children Hospital of ColoradoAuroraUnited States4
Children's Healthcare of AtlantaAtlantaUnited States47
Children's Hospital and Regional Medical Center - SeattleSeattleUnited States3
Children's Hospital Los AngelesLos AngelesUnited States6
Childrens Hospital Boston, Dana-Farber Cancer Institute.BostonUnited States4
Cincinnati Children's Hospital Medical CenterCincinnatiUnited States21
Cook Children's Healthcare SystemFort WorthUnited States3
Hospital for Sick ChildrenTorontoCanada76
UCSF Comprehensive Cancer CenterSan FranciscoUnited States1
University of Chicago, Comer Children's HospitalChicagoUnited States4
University of North CarolinaChapel HillUnited States101